96 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Teva confirms efficacy in late-stage trial of its migraine treatment for adult Chinese patients https://seekingalpha.com/news/4088897-teva-confirms-efficacy-in-late-stage-trial-of-its-migraine-treatment-for-adult-chinese-patients?source=feed_tag_israel Apr 11, 2024 - Late-stage study confirms efficacy and safety of Teva Pharmaceutical's AJOVY in preventing migraines in adult Chinese patients.
Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade) https://seekingalpha.com/article/4691152-teva-sustained-revenue-growth-amid-financial-strain-rating-downgrade?source=feed_tag_israel May 08, 2024 - Teva's blockbuster drugs continue to show robust growth and contribute to the company's revenue. See why TEVA stock is a Hold.
Teva wins FDA nod for new Austedo formulation https://seekingalpha.com/news/4111457-teva-wins-fda-nod-new-austedo-version?source=feed_tag_israel May 30, 2024 - Teva Pharmaceutical (TEVA) has gained FDA approval to market Austedo XR in four new dosing strengths in the U.S. Read more here.
Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) https://seekingalpha.com/article/4698647-teva-pharmaceutical-industries-limited-teva-goldman-sachs-45th-annual-global-healthcare?source=feed_tag_israel Jun 11, 2024 - Teva Pharmaceutical Industries Limited (NYSE:NYSE:TEVA) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024 8:00 AM ETCompany...
Teva asthma inhaler patents are 'improperly listed' in FDA Orange Book https://seekingalpha.com/news/4115251-teva-asthma-inhaler-patents-are-improperly-listed-in-fda-orange-book?source=feed_tag_israel Jun 12, 2024 - A New Jersey judge ruled that Teva's patents for its ProAir HFA inhaler were listed improperly in the FDA's Orange Book, benefiting Amneal Pharmaceuticals.
Teva focus of FTC investigation over inhaler patents https://seekingalpha.com/news/4121149-teva-focus-ftc-investigation-inhaler-patents?source=feed_tag_israel Jul 01, 2024 - The FTC has launched an investigation into Teva Pharmaceutical's refusal to withdraw patents allegedly delaying generic competition for asthma and COPD inhalers. read more here.
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs https://seekingalpha.com/article/4707032-teva-q2-earnings-preview-key-developments-biosimilars-pipeline-drugs?source=feed_tag_israel Jul 26, 2024 - Teva Pharmaceutical stock is up 69% since December. The company is set for Q2 earnings on July 31. See why I maintain my Hold rating on TEVA stock.
Teva Pharmaceutical Q2 2024 Earnings Preview https://seekingalpha.com/news/4130294-teva-pharmaceutical-q2-2024-earnings-preview?source=feed_tag_israel Jul 30, 2024 - Teva Pharmaceutical (TEVA) is set to announce Q2 earnings on July 31st.
Teva gains after lifting outlook on YTD performance https://seekingalpha.com/news/4130982-teva-stock-gains-revised-outlook?source=feed_tag_israel Jul 31, 2024 - Teva Pharmaceutical (TEVA) stock gained after the reported strong Q2 2024 financials, raising its full-year outlook. Read more here.
Teva Pharmaceutical Industries Limited 2024 Q2 - Results - Earnings Call Presentation https://seekingalpha.com/article/4708478-teva-pharmaceutical-industries-limited-2024-q2-results-earnings-call-presentation?source=feed_tag_israel Jul 31, 2024 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2024 Q2 earnings call.

Pages: 1234567...10

<Page 2>